REMEGEN (09995) is recommended to adopt the A-share stock incentive plan in 2023.
Connect global capital markets
REMEGEN (09995) announced that the board of directors recommends adopting the 2023 A-share stock incentive plan, planning to grant approximately 1.7831 million restricted stocks to the incentive beneficiaries. Upon the initial grant, 1.43245 million restricted stocks will be allocated, and approximately 0.3506 million restricted stocks will be reserved. The grant price (including reserved grants) is set at RMB 49.77 per A-share.
Related Articles
Sustainable products manufacturer Med-X (MXRX.US) files for Nasdaq listing, applies for direct listing.
HK Stock Market Move | VOYAH AUTO (07489) rises over 4%; right-hand drive models planned for launch in Hong Kong in Q4; company continues to advance overseas business.
HK Stock Market Move | ALEBUND-B(09637) rose nearly 8% in the afternoon as AP308/PKU308 received clinical trial authorization from the U.S. FDA.
Sustainable products manufacturer Med-X (MXRX.US) files for Nasdaq listing, applies for direct listing.
HK Stock Market Move | VOYAH AUTO (07489) rises over 4%; right-hand drive models planned for launch in Hong Kong in Q4; company continues to advance overseas business.
HK Stock Market Move | ALEBUND-B(09637) rose nearly 8% in the afternoon as AP308/PKU308 received clinical trial authorization from the U.S. FDA.
